Effects of Sample Clauses
POPULAR SAMPLE Copied 1 times
Effects of cancellation If you cancel this contract, we will reimburse to you all payments received from you. However, if you have requested that we start providing services to you during the fourteen (14) day cancellation period, on cancellation, you will pay us an amount which is in proportion to the cost of services which have been provided to you to that point, in comparison with the full coverage of the contract. We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of the reimbursement. For the avoidance of doubt, if you cancel this contract, all services will be terminated.
Effects of. Substitution. If the JDC determines to make the [**] Substitution, then the Parties will, for a period of [**] following the date of the [**] Substitution, negotiate the [**] with respect to replacing the Licensed [**] Products for [**]. If the Parties agree on such [**] and enter into a new agreement or an amendment of this Agreement within such [**] period (the date of such agreement, the “Licensed [**] Products Substitution Date”), then: [**].
Effects of. 16 weeks of caloric restriction on systolic and diastolic function in obese patients with type 2 diabetes mellitus.
A: atrial filling phase; E: early filling phase; E/Ea: estimated left ventricular filling pressure; ED: end-diastolic; ES: end-systolic; LV: left ventricular; LVEF: left ventricular ejection fraction.
Figure 4. Changes in myocardial function. Intraindividual changes in left ventricular (LV) mass (A) and the ratio between the early filling phase and the atrial filling phase (E/A ratio) after a 16-week very low calorie diet (VLCD) (B). ! A B *
Effects of. In the event of a Distracting Transaction that involves a Change of Control of Array and Array [***] as set forth in Section 4.4, then Sections 4.1, 4.2 and 4.3 shall terminate and Section 4.4 (with respect to subsequent Distracting Transactions) shall terminate, and on and after the date of the Distracting Transaction that involves a Change of Control of Array only
(i) Collaboration Technology and Compounds and Products within the Program as of the effective date of the Distracting Transaction (including ARRY-403), and (ii) if the Discovery Program continues after such effective date of the Distracting Transaction, any Collaboration Technology and Compounds and Products invented, discovered or created within the Discovery Program after the effective date of the Distracting Transaction, shall be Collaboration Technology hereunder for all purposes and shall be Compounds and Products hereunder for purposes of Article VI of this Agreement (such Compounds and Products, the “Program Products”), respectively. Amgen’s payment and other obligations hereunder with respect to Program Products shall continue unchanged (except as specified in Section 4.4). For products, other than Program Products, that satisfy the criteria in clause (iii) or (iv) of the definition of “Compound” in Section 1.34 (“Non-Program Products”), Amgen shall not have any obligations hereunder except that, (x) if the sale of a Non-Program Product would, but for the licenses granted hereunder to Amgen, infringe a Valid Claim within the Array Patents (other than Joint Patents) that is a composition of matter claim, then Amgen shall pay to Array royalties on Net Sales of such Non-Program Product pursuant to Section 6.5.1(b) (as if such Non-Program Product was a Product that does not contain ARRY-403) subject to the provisions of Section 6.5.2 and Sections 6.7 through 6.15 (as if the Non-Program Product was a Product), which royalties shall be payable on a country-by-country basis until the expiration of the last to expire Valid Claim within such Array Patents that is a composition of matter claim that would be infringed by the sale of such Non-Program Product in the country in which the applicable Non-Program Product is sold (which period shall be the Royalty Term for such Non-Program Product in such country), (y) if the manufacture, use or sale of a Non-Program Product would, but for the licenses granted hereunder to Amgen, infringe a Valid Claim within the Array Patents (other than Joint Patents)...
Effects of. During the period of time that non-probationary employees have recall rights as specified above, the following provisions shall be applicable to any non-probationary employees who are laid off by the Village:
a. An employee shall be paid for any earned but unused vacation days and time accrued to the effective date of layoff.
b. An employee shall have the right to maintain insurance coverage as set out in the federal COBRA law and the regulations promulgated thereunder.
c. If an employee is recalled, the amount of accumulated sick leave days that the employee had as of the effective day of the layoff shall be restored.
d. Upon recall, the employee's seniority shall be adjusted by the length of the layoff, that is, the period of layoff shall be excluded from the employee's seniority.